Stay updated on Nivolumab for High-Risk Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for High-Risk Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for High-Risk Prostate Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The study record now includes a Results Posted entry and updates to several primary and secondary outcomes (e.g., disease control rate at 12 weeks, PSA dynamics, radiographic progression, and treatment-related adverse events) along with related documents. Several older PSA-related outcomes were removed.
    Difference
    3%
    Check dated 2026-05-14T21:52:20.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Adds related-topic references for Prostate cancer and MedlinePlus Genetics to the page, improving quick access to background resources related to the study.
    Difference
    0.2%
    Check dated 2026-05-07T10:45:31.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The Study Record Dates section now shows Revision: v3.5.3 replacing v3.5.2, indicating an updated page revision. This reflects an administrative update to the record rather than changes to study information.
    Difference
    0.1%
    Check dated 2026-04-30T08:50:23.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2 in the page footer. No other visible changes to trial details or content.
    Difference
    0.1%
    Check dated 2026-04-15T22:09:26.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    A 'Results Submitted' section was added and the 'No Results Posted' note was removed.
    Difference
    0.2%
    Check dated 2026-04-01T10:20:33.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The page adds the Prostate cancer tag and related topics such as MedlinePlus Genetics. The site revision is updated from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-25T03:13:34.000Z thumbnail image

Stay in the know with updates to Nivolumab for High-Risk Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for High-Risk Prostate Cancer Clinical Trial page.